Results of a phase I, dose-escalating study of the safety, tolerability and anti-tumor activity of a single injection of a genetically engineered herpes simplex virus, NV1020, in subjects with hepatic colorectal metastases Meeting Abstract
| Authors: | Kemeny, N.; Jarnagin, W.; Guilfoyle, B.; Tufaro, F.; Karrasch, M.; Mescheder, A.; Ries, S.; Haag, N.; Fong, Y. |
| Abstract Title: | Results of a phase I, dose-escalating study of the safety, tolerability and anti-tumor activity of a single injection of a genetically engineered herpes simplex virus, NV1020, in subjects with hepatic colorectal metastases |
| Meeting Title: | 2nd ESMO Scientific and Educational Conference (ESEC) |
| Journal Title: | Annals of Oncology |
| Volume: | 16 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2005 Jun 2-5 |
| Meeting Location: | Budapest, Hungary |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2005-06-01 |
| Start Page: | ii283 |
| Language: | English |
| ACCESSION: | WOS:000229977400088 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdi739 |
| Notes: | Meeting Abstract 48O - Abstracts Section - ESMO Scientific and Educational Conference (ESEC) - JUN 02-05, 2005 - Budapest, HUNGARY - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
